Metastatic treatment of melanomas has progressed with the introduction of targeted therapy to BRAF and MEK inhibitors and immune checkpoint blockade to anti- PD-1, anti-PD-L1, and anti-CTLA4
Aim for at least 100 grams of protein daily, spread across meals
According to the Phase 3b, double-blind, placebo-controlled STRIDE study, Ozempic (1 mg) resulted in a superior and clinically meaningful improvement of 13% in maximum walking distance and a mean treatment difference of 39.9 meters on a steep incline compared to placebo at week 52 in adults with T2DM and PAD. If approved, Ozempic will be the only GLP-1 receptor agonist indicated for the treatment of PAD in patients with T2DM
People who begin at high concentration and daily use, expecting faster results, are the most frequent casualties
doi:10.1371/journal.pone.0236566
Rao R (2008) Oxidative stress-induced disruption of epithelial and endothelial tight junctions